Trial intelligence / Profile preview

Polypill Pilot Study in Iran

NCT00603590Phase 2Completed

Sponsor
Tehran University of Medical Sciences
Start
Nov 2006
Primary completion
Jun 2008
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of aspirin, hydrochlorothiazide, enalapril, atorvastatin in cardiovascular disease (CVD), sponsored by Tehran University of Medical Sciences. Started Nov 2006; status: completed.

02

Drugs

aspirinhydrochlorothiazideenalaprilatorvastatin
03

Conditions

cardiovascular disease (CVD)

Beyond the preview

Go deeper on NCT00603590.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00603590.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call